Assignee
ECCOGENE SHANGHAI CO LTD
CN·4 granted patents·1 pending application·17 citations·filing 2020–2022
Top patents by PatentIndex Score
5 records- 0195US11584751B1Substituted imidazoles as GLP-1 receptor agonistsECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Feb 21, 2023·14 cites·25 claims
- 0291US11780825B2Thyroid hormone receptor agonists and use thereofECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Oct 10, 2023·3 cites·25 claims
- 0372US11964942B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 0470US11472769B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·22 claims
- 0556US2022348564A1Phenyl-[1,3]dioxolo[4,5-c]pyridinyl-phenyl-, phenyl-[1,3]dioxolo[4,5-c]pyridinyl-heteroaryl-, or phenyl-(1,3)dioxo[4,5-c]pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo[d]imidazole-carboxylic acid derivatives and methods of using sameECCOGENE SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →